Skip to content

Investigation of the Hemodynamic Cardiac Profiler in assessing cardiac indices and clinical performance during exercise and cardiac stress

PROFILER study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON23429
Enrollment
60
Registered
2019-07-01
Start date
2017-07-02
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

stable ischemic heart disease

Interventions

None listed

Sponsors

Hemologic B.V.
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Healthy volunteers aged 18 and older (phase 1,2) and stable ischemic heart disease patients and cardiac rehabilitation completed (phase 3)

Exclusion criteria

Exclusion criteria: symptomatic heart failure, inability or any contraindication to perform physical exercise, unstable ischemic heart disease, planned coronary revascularization, any significant valve pathology (grade >2), history of any open heart surgery, any chest malformation, any metal implants in the thoracic area

Design outcomes

Primary

MeasureTime frame
two way random intraclass correlation coefficient and the associated 95% CI of the four measurements of change in stroke volume slope using the HCP during CPX in healthy volunteers and in patients.

Contacts

Public ContactHarald Jorstad

Amsterdam UMC - Location AMC

h.t.jorstad@amsterdamumc.nl0031624743041

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)